MedTrace Logo

Prevalence of BK Viremia in Simultaneous Liver-Kidney Transplant

NCT05224583 · Status: ENROLLING_BY_INVITATION · Type: OBSERVATIONAL · Enrollment: 50

Last updated 2026-03-20

No results posted yet for this study

Summary

The human BK polyomavirus is a significant risk factor for renal transplant dysfunction and allograft loss. The prevalence of BK viremia (BKV) following kidney transplantation is estimated to be 10-20%.

Conditions

  • Polyomavirus Infections
  • BK Viremia
  • Liver Transplant Infection
  • Kidney Transplant Infection

Interventions

PROCEDURE

Simultaneous Liver-Kidney Transplant

Simultaneous Liver-Kidney Transplant

Sponsors & Collaborators

  • Methodist Health System

    lead OTHER

Principal Investigators

  • Lori Kautzman, MD · Methodist Health System

Eligibility

Min Age
18 Years
Max Age
100 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-11-17
Primary Completion
2027-11-17
Completion
2028-11-17

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05224583 on ClinicalTrials.gov